Table 2

Summary of results

	Control group		Intervention group		Coefficient (SEM) method*	95% CI	p Value
	n	Mean (SD)	n	Mean (SD)	Coefficient (SEM) method*	95% CI	p Value
DNA, did not attend for clinic appointment; IBDQ, inflammatory bowel disease questionnaire; HADS, hospital anxiety and depression scale; 95% CI, 95% confidence interval.
*Coefficients and standard errors are adjusted for covariates. For linear regressions (R), the coefficient is the adjusted mean difference between control and intervention groups; for logistic and ordered logistic regressions (L and O), the adjusted odds ratio.
†Frequency of general practitioner (GP) visits is presented here for convenience as a percentage but the underlying data entered into the multivariable analysis were on an ordinal scale (no visits, 1, 2, 3–5, 6–10, 11 visits or more).
‡Adjusted for appointments kept in pre-trial year, entrance IBDQ, sex, age, and duration of illness.
§Adjusted for DNAs in the pre-trial year, appointments kept in the previous year, entrance IBDQ, sex, age, and duration of illness.
¶Adjusted for percentage who DNA in the pre-trial year, appointments kept in the previous year, entrance IBDQ, sex, age, and duration of illness.
**Adjusted for entrance IBDQ, sex, age, duration of illness, and diagnosis.
††Adjusted for entrance IBDQ, sex, age, duration of illness, and diagnosis
‡‡Adjusted for entrance HADS, sex, age, duration of illness, and diagnosis.
§§Adjusted for relapses in pre-trial year, entrance IBDQ, sex, age, duration of illness, and diagnosis.
¶¶Adjusted for GP visits in the pre-trial year, entrance IBDQ, sex, age, and duration of illness.
***Adjusted for entrance IBDQ, sex, age, duration of illness, diagnosis, and education.
Outcomes from hospital records
No of kept appointments during trial‡	364	3.0 (2.5)	274	1.9 (2.2)	−1.04 (0.19) R	−1.43 to −0.65	<0.001
No of DNAs during trial§	364	0.22 (0.78)	274	0.09 (0.34)	−0.08 (0.03) R	−0.15 to −0.01	0.034
Percentage of patients who DNA¶	364	12.1%	274	8.0%	0.66 (0.25) L	0.30 to 1.47	0.29
Outcomes from entrance questionnaire
Enablement (after initial consultation)**	352	3.0 (3.9)	260	4.0 (3.9)	0.90 (0.37) R	0.12 to 1.68	0.026
Satisfaction with initial consultation**	358	62.1 (12.3)	260	65.4 (12.0)	3.47 (1.95) R	−0.62 to 7.56	0.09
Outcomes from exit questionnaire
IBDQ††	296	167.7 (37.5)	236	172.3 (36.6)	1.94 (2.48) R	−3.27 to 7.15	0.45
HADS‡‡	306	12.3 (7.6)	242	11.7 (7.9)	−0.35 (0.41) R	−1.21 to 0.51	0.40
No of reported relapses during trial year§§	246	2.2 (2.5)	206	1.8 (2.2)	−0.36 (0.13) R	−0.63 to −0.09	0.013
Frequency of GP visits during trial year (% making no more than 2 visits)†¶¶	288	78.5%	232	81.9%	1.17 (0.24) O	0.75 to 1.81	0.47
% patients making appointment for themselves (excluding those with no appointments)***	250	22.0%	144	43.1%	2.70 (0.65) L	1.63 to 4.46	0.001